HemoSonics receives CE mark for liver transplant hemostasis assay tool

HemoSonics registered its new QStat Cartridge, an extension of its Quantra Hemostasis System, for CE Mark making it available in Europe and Hong Kong for use in trauma surgery and liver transplant procedures, according to a press release.
“Trauma and liver surgeries pose an enormous risk of acute bleeding,” Timothy J. Fischer, president and CEO of HemoSonics, said in the release. “What makes the new QStat Cartridge unique is its unparalleled ease of use and its innovative coagulation tests for critical injury and liver transplant, including platelet contribution to clot

Source link

Related posts

Health care use indicators linked to IBD-related disability


Early-Onset Colorectal Cancer in Li Fraumeni Syndrome Patients: Is It Really Enough to Justify Early Colon Cancer Screening?


ATP released by intestinal bacteria limits the generation of protective IgA against enteropathogens


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy